#venture capital

Are we valuing flashy biotech startups over actual, slow-burn basic research?

Would you ever put serious money into a domain portfolio over actual web startups?

Should founders take a salary or reinvest every dollar until the company dies?

Is scaling a startup with venture capital worth the stress or just overrated?

Do synthetic biology startups add real value, or mostly hype hoping for a patent sell-off?

How do you spot a startup that’s actually worth your time versus hype?

Is Y Combinator worth the equity cost for a deep-tech startup?

Are 'disruptive' startups really just copying old ideas and adding a fancy app?

Are pitch decks and venture capital just a high-stakes popularity contest, or does all that polish really separate winners from losers?

Do VCs secretly prefer flashy ideas over profitable businesses, and is that ruining entrepreneurship?

Is the real startup gatekeeper actually the “serial founder” badge—earned or just polished for LinkedIn?

Do you actually need venture capital to succeed, or is bootstrapping the only real way to build a sustainable company?

Should you still invest in biotech startups after recent supply chain disruptions?

“Are green business models overrated when most startups fail within five years?”

Is sustainability still a priority for venture capital funding decisions?

Is the AI hype in startups just adding costs, not value?

How do you actually value a pre-revenue startup without relying on fluff metrics?

Does a startup’s valuation say more about hype than actual viability?

After recent VC pullbacks, are you rethinking bootstrapping?

Is climate tech just a get-rich-quick scheme for Silicon Valley, or our real way out?